Samuel Agresta serves as Executive at Foghorn Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Samuel Agresta has executed 2 insider transactions totaling $2.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 16, 2023 involved selling 311,297 shares valued at $2.6M.
Samuel Agresta currently holds 311,297 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel Agresta has been a net seller of FHTX stock. They have purchased $0 and sold $2.6M worth of shares.
Samuel Agresta's most recent insider trade was on Aug 16, 2023, when they sold 311,297 shares at $8.25 per share.
Get notified when new Form 4 filings are submitted
| $3.72 |
| Discretionary |